Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, Dec. 17, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and...
Yeelight Launches Smart Home Hub: A Next-Generation Multi-Protocol Gateway for a Unified Smart Home Experience
LOS ANGELES, Nov. 21, 2025 /PRNewswire/ -- Yeelight, an industry leader in smart lighting and IoT solutions, today announced the launch of its first multi-protocol smart home gateway — the Yeelight Smart Home Hub. Certified as Matter Compatible,...